Public Release: 

New model for possible malaria vaccination suggests mass vaccination for low transmission areas

PLOS

In the event that a vaccine for the prevention of malaria is licensed and ready for use (such as the research malaria vaccine RTS,S, which currently looks promising), distributing and giving the vaccine to three-month old infants via the World Health Organization's Expanded Programme on Immunization (EPI) will be the most efficient mechanism in high transmission areas but for lower transmission areas, mass vaccination every 5 years might be a more efficient vaccination strategy, a new study has found.

In a modelling study led by Thomas Smith from the Public Health Institute in Basel, Switzerland, and published in this week's PLoS Medicine, the authors used 14 different models that simulated the transmission of the parasite that causes malaria (P. falciparum) in thousands of hypothetical individuals through different stages of malaria infection. The authors used each model to predict the health benefits over 14 years of the potential malaria vaccine RTS,S given by different vaccination strategies and found that the predicted benefits of giving the malaria vaccine using the EPI strategy were modest and similar over a wide-range of settings. However, EPI with an initial catch-up phase averted the most deaths per vaccine dose in individuals who had over 10 infectious malaria bites a year but in areas where people typically have two or less infectious mosquito bites a year, the authors' model found that mass vaccination strategies substantially reduced transmission leading to much greater health effects per dose than other strategies, even at modest coverage.

This study only reports the first stages of using ensemble modelling to predict the health effects of RTS,S vaccination, so future studies will need to combine the outputs of multiple models with economic analyses to provide a rational basis for the design of vaccine-containing malaria control and elimination programs.

The authors say: "The ensemble modeling approach provides more robust outcomes than single models, and our analyses suggest that such an approach produces greater confidence in predictions of health effects for lower malaria transmission settings than for higher ones."

The authors continue: "This study suggests that targeted mass vaccination with RTS,S in low transmission settings may be more efficient than national-level introduction via EPI programs, but there remains a need to analyze the feasibility and economics of such strategies and the circumstances in which vaccination will avert epidemics."

###

Funding: This research was supported by the Bill & Melinda Gates Foundation grant 39777.01 and by the Malaria Vaccine Initiative. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: Thomas A. Smith is on the Editorial Board of PLoS Medicine. AB used to be employed by the PATH Malaria Organization which was supporting the development of RTS,S, the vaccine which is the focus of this paper. AB left PATH prior to any collaboration on this paper. All other authors have declared no competing interests. The views expressed are those of the authors.

Citation: Smith T, Ross A, Maire N, Chitnis N, Studer A, et al. (2012) Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine. PLoS Med 9(1): e1001157. doi:10.1371/journal.pmed.1001157

CONTACT:

Thomas Smith

Swiss Tropical & Public Health Institute
Socinstrasse 57
Basel, CH 4002
Switzerland
+41 (0) 61-284 8273
thomas-a.smith@unibas.ch

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.